PHARVARIS NV(NASDAQ:PHVS) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to PHVS. PHVS was compared to 198 industry peers in the Pharmaceuticals industry. PHVS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PHVS does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

PHVS had negative earnings in the past year.

In the past year PHVS has reported a negative cash flow from operations.

In the past 5 years PHVS always reported negative net income.

PHVS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PHVS has a Return On Assets (-46.06%) which is comparable to the rest of the industry.

Looking at the Return On Equity, with a value of -50.13%, PHVS is in line with its industry, outperforming 55.56% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-46.06%
ROE	-50.13%
ROIC	N/A

ROA(3y)-38.96%

ROA(5y)-32.55%

ROE(3y)-42.51%

ROE(5y)-35.1%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PHVS so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, PHVS has more shares outstanding

PHVS has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, PHVS has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 15.38 indicates that PHVS is not in any danger for bankruptcy at the moment.

With an excellent Altman-Z score value of 15.38, PHVS belongs to the best of the industry, outperforming 92.93% of the companies in the same industry.

A Debt/Equity ratio of 0.00 indicates that PHVS is not too dependend on debt financing.

With a decent Debt to Equity ratio value of 0.00, PHVS is doing good in the industry, outperforming 62.63% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	15.38

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

PHVS has a Current Ratio of 12.60. This indicates that PHVS is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of PHVS (12.60) is better than 88.38% of its industry peers.

A Quick Ratio of 12.60 indicates that PHVS has no problem at all paying its short term obligations.

PHVS has a Quick ratio of 12.60. This is amongst the best in the industry. PHVS outperforms 88.38% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	12.6
Quick Ratio	12.6

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.06% over the past year.

EPS 1Y (TTM)6.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%15.79%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

PHVS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.66% yearly.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-37.11%

EPS Next 2Y-14.81%

EPS Next 3Y-0.83%

EPS Next 5Y25.66%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PHVS. In the last year negative earnings were reported.

Also next year PHVS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-14.81%

EPS Next 3Y-0.83%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for PHVS!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PHARVARIS NV

NASDAQ:PHVS (4/22/2025, 12:16:42 PM)

14.98

+0.48 (+3.31%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)04-07 2025-04-07/bmo

Earnings (Next)05-07 2025-05-07/amc

Inst Owners59.08%

Inst Owner Change0%

Ins Owners9.49%

Ins Owner ChangeN/A

Market Cap816.26M

Analysts84.29

Price Target35.7 (138.32%)

Short Float %1.5%

Short Ratio9.99

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-5.32%

Min EPS beat(2)-23.64%

Max EPS beat(2)12.99%

EPS beat(4)3

Avg EPS beat(4)0.33%

Min EPS beat(4)-23.64%

Max EPS beat(4)12.99%

EPS beat(8)6

Avg EPS beat(8)-2.06%

EPS beat(12)9

Avg EPS beat(12)0.55%

EPS beat(16)11

Avg EPS beat(16)-7.81%

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)2.56%

EPS NQ rev (1m)-5.04%

EPS NQ rev (3m)-8.52%

EPS NY rev (1m)-10.6%

EPS NY rev (3m)-10.6%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	2.68
P/tB	2.68
EV/EBITDA	N/A

EPS(TTM)-2.82

EYN/A

EPS(NY)-3.86

Fwd EYN/A

FCF(TTM)-2.52

FCFYN/A

OCF(TTM)-2.5

OCFYN/A

SpS0

BVpS5.58

TBVpS5.58

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-46.06%
ROE	-50.13%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-38.96%

ROA(5y)-32.55%

ROE(3y)-42.51%

ROE(5y)-35.1%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	199.59%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	12.6
Quick Ratio	12.6
Altman-Z	15.38

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)104.84%

Cap/Depr(5y)175.41%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)6.06%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%15.79%

EPS Next Y-37.11%

EPS Next 2Y-14.81%

EPS Next 3Y-0.83%

EPS Next 5Y25.66%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-50.31%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-18.78%

EBIT Next 3Y11.65%

EBIT Next 5YN/A

FCF growth 1Y-29.56%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-29.1%

OCF growth 3YN/A

OCF growth 5YN/A

PHARVARIS NV (PHVS) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens